Improving immunotherapy of hepatocellular carcinoma (<scp>HCC</scp>) using dendritic cells (<scp>DC</scp>) engineered to express <scp>IL</scp>‐12 <i>in vivo</i>
Annabelle Vogt(University of Bonn), Maria A. González-Carmona(University of Bonn), Tilman Sauerbruch(University Hospital Bonn), Elisabeth Sievers(Karolinska University Hospital), E Raskopf(University of Bonn), Hildegard Büning(Medizinische Hochschule Hannover), Christian P. Strassburg(University Hospital Bonn), Ingo G.H. Schmidt‐Wolf(University Hospital Bonn), Nadja Meumann(University of Cologne), Veronika Lukacs‐Kornek(University Hospital Bonn), G. Anton Decker
Cited by 30
Related Papers
Bowel preparation before colonoscopy
|Gastrointestinal Endoscopy|2015|475
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
|Fibrogenesis & Tissue Repair|2013|330
Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury
|Hepatology|2016|323
The tumour microenvironment and immune milieu of cholangiocarcinoma
|Liver International|2019|194